• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国乳腺癌的诊断年龄:比美国和欧盟早近10年。

Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union.

作者信息

Song Qing-Kun, Li Jing, Huang Rong, Fan Jin-Hu, Zheng Rong-Shou, Zhang Bao-Ning, Zhang Bin, Tang Zhong-Hua, Xie Xiao-Ming, Yang Hong-Jian, He Jian-Jun, Li Hui, Li Jia-Yuan, Qiao You-Lin, Chen Wan-Qing

机构信息

Beijing Key Laboratory of Cancer Therapeutic Vaccine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China E-mail :

出版信息

Asian Pac J Cancer Prev. 2014;15(22):10021-5. doi: 10.7314/apjcp.2014.15.22.10021.

DOI:10.7314/apjcp.2014.15.22.10021
PMID:25520063
Abstract

BACKGROUND

The study aimed to describe the age distribution of breast cancer diagnosis among Chinese females for comparison with the United States and the European Union, and provide evidence for the screening target population in China.

MATERIALS AND METHODS

Median age was estimated from hospital databases from 7 tertiary hospitals in China. Population-based data in China, United States and European Union was extracted from the National Central Cancer Registry, SEER program and GLOBOCAN 2008, respectively. Age-standardized distribution of breast cancer at diagnosis in the 3 areas was estimated based on the World Standard Population 2000.

RESULTS

The median age of breast cancer at diagnosis was around 50 in China, nearly 10 years earlier than United States and European Union. The diagnosis age in China did not vary between subgroups of calendar year, region and pathological characteristics. With adjustment for population structure, median age of breast cancer at diagnosis was 5054 in China, but 5559 in United States and European Union.

CONCLUSIONS

The median diagnosis age of female breast cancer is much earlier in China than in the United States and the European Union pointing to racial differences in genetics and lifestyle. Screening programs should start at an earlier age for Chinese women and age disparities between Chinese and Western women warrant further studies.

摘要

背景

本研究旨在描述中国女性乳腺癌诊断的年龄分布情况,以便与美国和欧盟进行比较,并为中国的筛查目标人群提供依据。

材料与方法

从中国7家三级医院的数据库中估算中位年龄。中国、美国和欧盟基于人群的数据分别从国家中央癌症登记处、监测、流行病学和最终结果(SEER)计划以及全球癌症观察站2008中提取。根据2000年世界标准人口估算这3个地区乳腺癌诊断时的年龄标准化分布。

结果

中国乳腺癌诊断的中位年龄约为50岁,比美国和欧盟早近10年。中国的诊断年龄在历年、地区和病理特征亚组之间没有差异。调整人口结构后,中国乳腺癌诊断的中位年龄为50至54岁,而美国和欧盟为55至59岁。

结论

中国女性乳腺癌的中位诊断年龄比美国和欧盟早得多,这表明在遗传和生活方式方面存在种族差异。中国女性的筛查计划应从更早的年龄开始,并且中国和西方女性之间的年龄差异值得进一步研究。

相似文献

1
Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union.中国乳腺癌的诊断年龄:比美国和欧盟早近10年。
Asian Pac J Cancer Prev. 2014;15(22):10021-5. doi: 10.7314/apjcp.2014.15.22.10021.
2
Breast Cancer Disparities: A Multicenter Comparison of Tumor Diagnosis, Characteristics, and Surgical Treatment in China and the U.S.乳腺癌差异:中国与美国肿瘤诊断、特征及手术治疗的多中心比较
Oncologist. 2015 Sep;20(9):1044-50. doi: 10.1634/theoncologist.2014-0290. Epub 2015 Aug 3.
3
Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.澳大利亚原住民和托雷斯海峡岛民妇女的乳房筛查与乳腺癌生存率
Asian Pac J Cancer Prev. 2012;13(1):147-55. doi: 10.7314/apjcp.2012.13.1.147.
4
Disease Severity, Presentation, and Clinical Outcomes Among Adolescents With Malignant Breast Neoplasms: A 20-Year Population-Based Outcomes Study From the SEER Database (1973-2009).青少年恶性乳腺肿瘤的疾病严重程度、表现和临床结局:来自 SEER 数据库的 20 年基于人群的结局研究(1973-2009 年)。
Clin Breast Cancer. 2017 Aug;17(5):392-398. doi: 10.1016/j.clbc.2017.03.006. Epub 2017 May 8.
5
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.按肿瘤组织学分析新诊断的IV期乳腺癌发病率和生存率的时间趋势:一项基于人群的分析。
Breast Cancer Res Treat. 2016 Jun;157(3):587-96. doi: 10.1007/s10549-016-3845-5. Epub 2016 Jun 6.
6
Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies.中国乳腺癌面临的挑战与筛查:来自当前登记数据和人群筛查研究的经验教训
Oncologist. 2015 Jul;20(7):773-9. doi: 10.1634/theoncologist.2014-0351. Epub 2015 May 22.
7
Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.伊朗女性乳腺癌:按年龄组、形态学及趋势划分的发病率
Asian Pac J Cancer Prev. 2016;17(3):1393-7. doi: 10.7314/apjcp.2016.17.3.1393.
8
Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.基于人群的乳腺癌发病率和生存结局分析:诊断为乳腺小叶原位癌的女性。
Ann Surg Oncol. 2017 Sep;24(9):2509-2517. doi: 10.1245/s10434-017-5867-6. Epub 2017 Apr 28.
9
Breast cancer in young women from a low risk population in Nepal.尼泊尔低风险人群中年轻女性的乳腺癌
Asian Pac J Cancer Prev. 2013;14(9):5095-9. doi: 10.7314/apjcp.2013.14.9.5095.
10
Incidence and mortality of female breast cancer in Jiangsu, China.中国江苏省女性乳腺癌的发病率和死亡率。
Asian Pac J Cancer Prev. 2014;15(6):2727-32. doi: 10.7314/apjcp.2014.15.6.2727.

引用本文的文献

1
Comparative study of early onset cancer burden between China and the United States from 1990 to 2021.1990年至2021年中美两国早发性癌症负担的比较研究。
Sci Rep. 2025 Aug 5;15(1):28527. doi: 10.1038/s41598-025-10185-w.
2
Maternal knowledge, attitudes, and practices regarding breastfeeding and mastitis.母亲关于母乳喂养和乳腺炎的知识、态度及做法。
BMC Pregnancy Childbirth. 2025 Jul 10;25(1):748. doi: 10.1186/s12884-025-07867-8.
3
Spatial and temporal changes of breast-conserving surgery rates and its influential factors among Chinese patients with breast cancer from 2013 to 2019: a registry-based study.
2013年至2019年中国乳腺癌患者保乳手术率的时空变化及其影响因素:一项基于登记处的研究
BMJ Open. 2025 Feb 2;15(1):e089188. doi: 10.1136/bmjopen-2024-089188.
4
The burden and long-term trends of breast cancer by different menopausal status in China.中国不同绝经状态下乳腺癌的负担及长期趋势
J Natl Cancer Cent. 2024 Jul 2;4(4):326-334. doi: 10.1016/j.jncc.2024.04.007. eCollection 2024 Dec.
5
Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019.1990年至2019年中国女性癌症疾病负担及危险因素趋势
Int J Public Health. 2024 Dec 4;69:1607245. doi: 10.3389/ijph.2024.1607245. eCollection 2024.
6
Assessing the performance of large language models (LLMs) in answering medical questions regarding breast cancer in the Chinese context.评估大语言模型(LLMs)在中国背景下回答有关乳腺癌医学问题的表现。
Digit Health. 2024 Oct 7;10:20552076241284771. doi: 10.1177/20552076241284771. eCollection 2024 Jan-Dec.
7
Community Pharmacists' Readiness for Breast Cancer Mammogram Promotion: A National Survey from Jordan.社区药剂师对乳腺癌乳房X光造影推广的准备情况:来自约旦的全国性调查。
J Multidiscip Healthc. 2024 Sep 18;17:4475-4489. doi: 10.2147/JMDH.S471151. eCollection 2024.
8
Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients.青年乳腺癌患者诊断、治疗及生育管理的专家共识
J Natl Cancer Cent. 2021 Feb 25;1(1):23-30. doi: 10.1016/j.jncc.2021.02.001. eCollection 2021 Mar.
9
The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019.1990年至2030年全球女性乳腺癌负担:基于2019年全球疾病负担研究的评估与预测
Front Oncol. 2024 Jun 20;14:1364397. doi: 10.3389/fonc.2024.1364397. eCollection 2024.
10
Risk factors for self-reported high symptom cluster burdens in patients with breast cancer undergoing chemotherapy in China: A cross-sectional study.中国接受化疗的乳腺癌患者自我报告的高症状群负担的危险因素:一项横断面研究。
Health Sci Rep. 2024 Jun 19;7(6):e2188. doi: 10.1002/hsr2.2188. eCollection 2024 Jun.